Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target E2F1 (clone L0Z35L7J). We employs the HBV (CMV-Cy3-PAX-PstI) vector components and the SynExpress system of the miRNA Knock-in/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
E2F1
Clone
L0Z35L7J
Species Reactivity
Human; Mouse
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
PAX
Insertion Sites
PstI
Gene Modification
Knock-in
Modification Domain
miRNA
Carrier Type
HBV
Transformation Accuracy
0.88
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.